T H E L A B ' S L A T E S T

UNITED KINGDOM SOUTH AFRICA

Thousands of patients with multiple sclerosis are to benefit from a new 10-minute injection on the NHS that can help slow the progression of disability while cutting their treatment time in hospital by over 90 %. Around 9,000 patients in England currently receiving the drug ocrelizumab via an infusion can now be offered a jab that takes just ten minutes , following approval from the Medicines and Healthcare products Regulatory Agency , enabling them to spend less time in hospital receiving treatment .

Sanofi and Biovac , a Cape Town , South Africa-based biopharmaceutical company , announce their local manufacturing partnership to produce inactivated polio vaccines ( IPV ) in Africa . This agreement is designed to enable regional manufacturing of polio vaccines to serve the potential needs of over 40 African countries . This partnership with Sanofi makes Biovac the first African producer of IPV on and for the African continent and supports the Africa Centers for Disease Control and Prevention ’ s ambition to have 60 percent of local vaccines produced in Africa by 2040 .

www . intelligenthealth . tech 23